Insider Trading History of Benjamin Regina M.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Benjamin Regina M. since 2018. This trader's CIK number is 1594511. At the time of last reporting, Benjamin Regina M. was the Officer of Doximity, Inc.. (stock ticker symbol DOCS). Also see all insider trading activities at Doximity, Inc..

Note that in the past Benjamin Regina M. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Diplomat Pharmacy, Inc. (DPLO) by Benjamin Regina M.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 DPLO 0 $0 2,133 $10,342 0 $0
2018 DPLO 0 $0 1,680 $40,765 0 $0

Yearly summary of insider trading at Doximity, Inc. (DOCS) by Benjamin Regina M.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 DOCS 0 $0 55,000 $3,985,080 0 $0
2022 DOCS 0 $0 10,000 $586,820 0 $0
2021 DOCS 0 $0 105,862 $7,953,412 0 $0


Insider trading activities at 2 companies by Benjamin Regina M.:

1. Diplomat Pharmacy, Inc. (DPLO)

2. Doximity, Inc. (DOCS)

Table 1. Insider trading of Diplomat Pharmacy, Inc. (DPLO) by Benjamin Regina M.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-10-02 DPLO Sale 859 4.84 4,157
2019-06-04 DPLO Sale 1,274 4.86 6,185
2018-06-05 DPLO Sale 1,680 24.27 40,765

Table 2. Insider trading of Doximity, Inc. (DOCS) by Benjamin Regina M.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-11 DOCS Sale 5,000 60.04 300,200
2025-06-25 DOCS Sale 10,000 60.00 600,000
2025-02-11 DOCS Sale 40,000 77.12 3,084,880
2022-02-11 DOCS Sale 10,000 58.68 586,820
2021-11-12 DOCS Sale 105,862 75.13 7,953,412

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Benjamin Regina M. (Officer of Doximity, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.